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ABSTRACT 
Glycoprotein mRNA (G mRNA) of vesicular stomatitis virus is synthesized in the 
cytosol  fraction  of  infected  HeLa  cells.  Shortly  after  synthesis,  this  mRNA 
associates with 40S ribosomal subunits and subsequently forms 80S monosomes in 
the cytosol fraction. The bulk of labeled G  mRNA  is then found in polysomes 
associated with the membrane, without first appearing in the subunit or monomer 
pool  of the  membrane-bound  fraction.  Inhibition  of  the  initiation  of protein 
synthesis by pactamycin or muconomycin A  blocks entry of newly synthesized G 
mRNA into membrane-bound polysomes. Under these circumstances, labeled G 
mRNA accumulates in the cytosol. Inhibition of the elongation of protein synthe- 
sis  by  cycloheximide, however,  allows  entry  of 60%  of newly  synthesized  G 
mRNA  into  membrane-bound  polysomes.  Furthermore,  prelabeled  G  mRNA 
associated  with  membrane-bound  polysomes  is  released  from  the  membrane 
fraction in vivo by pactamycin or muconomycin A  and in vitro by 1 mM puromy- 
cin -  0.5 M KC1. This release is not due to nonspecific effects of the drugs. These 
results  demonstrate  that  association  of G  mRNA  with  membrane-bound  poly- 
somes is dependent upon polysome formation and initiation of protein synthesis. 
Therefore, direct association of the 3' end of G  mRNA with the membrane does 
not appear to be the initial event in the formation of membrane-bound polysomes. 
In  eukaryotic  cells,  polyribosomes  are  found 
either free in the cytoplasm  or in association  with 
membranes comprising the rough endoplasmic re- 
ticulum  (RER) (35). The percentage of polyribo- 
somes in  each  class is  dependent  upon  the  cell 
type, and cells synthesizing  large  amounts of se- 
cretory  proteins  contain  a  high  proportion  of 
membrane-bound polysomes (35). Furthermore, 
it  has been  demonstrated that proteins secreted 
from the cell are synthesized  primarily on mem- 
brane-bound polysomes, whereas protein serving 
intraceUular functions are synthesized primarily on 
free polysomes (12,  17,  37).  Dallner et al.  (10, 
11)  and Lodish and Small  (25) have postulated 
that membrane-bound polysomes also synthesize 
proteins which became structural units of various 
membrane fractions. 
From many studies,  it appears that mRNAs for 
specific cellular functions are segregated in eukar- 
yotic cells; however, the mechanism for this segre- 
gation  process has not been fully elucidated (12, 
17,  37).  Certain  investigators  have  reported  a 
direct association  of mRNA with membranes via 
the  3'  poly (A)  and/or adjacent  regions of the 
messenger and have suggested  that specificity for 
mRNA-membrane interaction may reside in  the 
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Blobel  and  co-workers  (3,  5,  6)  have  obtained 
evidence  for  an  alternative  mechanism  in  which 
the specificity for segregation  of mRNA in mem- 
brane-bound polysomes is conferred by a common 
N-terminal  hydrophobic  nascent  polypeptide 
chain  for  all  secretory  proteins.  This  region, 
termed  the  "signal  sequence",  is  cleaved before 
completion  of protein  synthesis  and  does  not ap- 
pear in the final secreted product. 
In the present study, we have examined interac- 
tion  of  a  specific eukaryotic  mRNA  with  mem- 
branes,  utilizing vesicular stomatitis virus (VSV)- 
infected  HeLa  cells.  VSV-infected  cells  contain 
two size classes  of viral specific mRNAs of sedi- 
mentation  values 26S  and  12-18S  (19,  33).  The 
12-18S  size class  can  be  subdivided  further  into 
17S, 14.5S and  12S species (15, 40, 41). The 17S 
viral specific mRNA codes for glycoprotein G  (7, 
15,  22,  32)  and  is  found  on  membrane-bound 
polysomes. The 14.5S and 12S VSV mRNAs code 
for nucleocapsid  (N),  membrane  matrix  (M)  and 
NS proteins and are found predominantly on free 
polysomes (7,  15, 22, 32).  We have attempted to 
follow the fate of G  mRNA from  the time of its 
synthesis to  its association  with polysomes in the 
membrane.  We  have  found  that  glycoprotein 
mRNA  (G  mRNA)  is synthesized  in  the  cytosol 
and then rapidly associates with membrane-bound 
polysomes.  Pactamycin  and  muconomycin  A, in- 
hibitors  of initiation  of protein  synthesis,  almost 
totally  block  association  of  G  mRNA  with  the 
membrane  fraction.  In  contrast,  cycloheximide, 
an inhibitor of elongation, allows association of G 
mRNA  with  membrane-bound  polysomes  to  a 
level -60%  that  found  in  control  infected  cells. 
Furthermore,  puromycin  -0.5  M  KC1 specifically 
releases labeled VSV mRNA from membranes of 
infected  cells,  indicating  that  the  nascent  chain 
serves as an  anchor for attachment  of polysomes 
containing VSV mRNA. These results are consist- 
ent  with  an  interpretation  that  events  early  in 
protein  synthesis,  related  to  formation  of the N- 
terminal peptide, are required before glycoprotein 
G  mRNA enters into a stable complex with mem- 
brane  structures. 
MATERIALS  AND  METHODS 
Suspension  cultures of HeLa cells were grown at 37~  to 
a concentration of 4-8 ￿  105 celis/ml in Eagle's medium 
(MEM)  supplemented  with  2  mM glutamine  and  7% 
fetal calf serum. Vesicular stomatitis virus (Indiana sero- 
type) was grown as previously described (16). Actinomy- 
cin D was a gift of Merck Chemical Div., Merck & Co. 
Inc.,  Rahway,  N.J.,  and  muconomycin  A  was  kindly 
provided by  Dr.  Susan  Horwitz of the  Department  of 
Pharmacology,  Albert  Einstein  College  of  Medicine, 
New York. Isotopes were obtained from New England 
Nuclear Corp., Boston, Mass. All glassware,  buffers and 
sucrose  solutions were autoclaved. 
Infection of HeLa Cells 
Log-phase HeLa cells were concentrated to a density 
of 4  ￿  10  ~ cells/ml and infected with VSV at a multiplic- 
ity of infection (MOI) of 10 PFU/cell. 1 h postinfection, 
actinomycin  D was added to 5/zg/ml and fetal calf serum 
was added  1.5  h  postinfection.  [3H]uridine  (30-40  Ci/ 
mmol, 30 /.tCi/ml) was added 2.5  h postinfection or as 
stated  in  the  appropriate  figure  legend.  Inhibitors  of 
protein synthesis  were added  as indicated.  Labeling of 
infected  cells  was  stopped  by  pouring  the  cells  over 
frozen, crushed Earle's solution. 
Preparation  of Cytoplasmic Extracts 
Cells were harvested by centrifugation, washed with 
Earle's solution and resuspended in RSB (0.01 M NaCI, 
0.01  M Tris-HC1,  pH 7.4,  and 0.0015  M MgCl2) con- 
taining 100/~g/ml heparin. The cells were left at 0~  for 
10-15 rain and then lysed with a glass Dounce homoge- 
nizer. Cell lysis was monitored by light microscopy. Nu- 
clei were removed by centrifugation at  1,600  rpm for 3 
min and the crude cytoplasmic  extract was separated into 
a  cytoplasmic  pellet and  a  postmembrane  supernatant 
fraction by centrifugation at 13,000 rpm for 30 min. The 
cytoplasmic  pellet  was  resuspended  in  isotonic  buffer 
(0.15  M  NaCl,  0.01  M  Tris-HCl,  pH  7.4,  0.0015  M 
MgCl2) containing 100  p,g/ml heparin and layered over 
replicate 35-ml  15-30% (wt/wt) linear sucrose gradients 
in isotonic buffer and 100 p,g/ml heparin. Centrifugation 
was  carried  out  at  4~  in  a  Beckman  #SW27  rotor 
(Beckman  Instruments  Inc.,  Spinco  Div.,  Palo  Alto, 
Calif.) at 25,000 rpm for 30 rain. The pellet, containing 
membrane-bound  polysomes,  was  resuspended  in  iso- 
tonic  buffer  containing  the  nonionic detergent  NP-40 
and used directly for separation of polysomes and ribo- 
somal  subunits  or adjusted  to  a  final sodium  dodecyl 
sulfate  (SDS) concentration of 1% for analysis of RNA. 
The postmembrane supernatant  fraction was also sepa- 
rated into polysomes and ribosomal subunits  after addi- 
tion  of  the  NP-40  or  was  analyzed  directly for  VSV 
mRNA components. 
Sucrose Gradient  Centrifugation  o  f  the 
Membrane Pellet or Postmembrane 
Supernatant  Fraction 
Membrane pellets or postmembrane supernatant frac- 
tions were layered over replicate 35-ml 7-52%  (wt/wt) 
linear sucrose gradients in isotonic buffer, containing 100 
/zg/ml  heparin,  and  were centrifuged in  the  Beckman 
#SW27 rotor at 4~  for 16 h at 16,000 rpm. Gradients 
were  collected  through  an  Altex  automatic  recording 
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Berkeley, Calif.). Small portions of each fraction were 
analyzed for radioactive RNA by TCA precipitation and 
liquid scintillation  spectroscopy as described previously 
(16). In order to determine whether [SH]uridine-labeled 
RNA in  the 40S region was  associated with  40S ribo- 
somal subunits  or was present as mRNPs, this region of 
the gradient was rerun on a second 35-ml 15-30% (wt/ 
wt) linear sucrose gradient in isotonic buffer containing 
100  /~g/ml  heparin.  Centrifugation  in  the  Beckman 
#SW27 rotor was carried out at 4~  for 15 h at 25,000 
rpm. Gradients were collected as described above, and 
small portions of each fraction were analyzed for radio- 
active RNA. Appropriate fractions from each gradient 
were pooled and  precipitated  with 2.5  vol of absolute 
ethanol for subsequent analysis of VSV mRNA compo- 
nents. 
Sucrose  Gradient Analysis of VSV mRNA 
Fractions in ethanol were precipitated by centrifuga- 
tion at  12,000  rpm for 30 min, resuspended  in  NETS 
buffer  (0.1  M  NaCl,  0.01  M  Tris,  pH  7.4,  0.002  M 
EDTA and  0.1%  SDS),  layered on  11.6-ml  15-30% 
(wt/wt) sucrose gradients  in  NETS buffer, and  centri- 
fuged in a Beckman  #SW41  rotor at 23~  for 17 h at 
33,000  rpm.  Gradients  were  monitored  as  indicated 
above. 
RESULTS 
Synthesis  and Subcellular  Localization 
of VSV G mRNA 
To  analyze  subcellular  sites  for  synthesis  and 
accumulation  of VSV mRNAs,  HeLa  cells were 
infected with VSV and at appropriate  time points 
postinfection  aliquots  of cells  were  labeled  with 
[3H]uridine  for 5,  20,  or  120  min.  In  each case, 
the time at which the cells were harvested was 4.5 
h postinfection. After the various labeling periods, 
membrane-bound  and  non-membrane-bound 
fractions  were  prepared  and  the  distribution  of 
[3H]uridine-labeled  12-18S  viral  mRNA  species 
determined  (Fig.  1). After a  5-min pulse, labeled 
17S mRNA is present  in both  the nonmembrane 
and membrane-bound fractions, although the pro- 
portion  of  labeled  17S  mRNA  in  total  12-18S 
mRNA is higher in the membrane-bound fraction 
(Fig.  1 A  and  D).  After a  20-min pulse, the rela- 
tive proportions  of labeled  14.5S  and  12S  VSV 
mRNAs  increase  in  the  nonmembrane  fraction 
(Fig.  1 B), whereas the proportion  of labeled  17S 
mRNA increases in the membrane-bound fraction 
(Fig. 1 E). The profile for 12-18S VSV mRNAs in 
the membrane-bound and nonmembrane fractions 
changes  only  slightly  between  20  min  and  120 
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FIGURE  1  Sucrose  gradient  analysis  of  12-18S  VSV 
mRNA in infected HeLa cells after 5, 20 and 120 min of 
[SH]uridine labeling. HeLa cells were infected with VSV, 
and, at various times postinfection, 0.75  x  108 infected 
cells were labeled with 0.75  mCi [aH]uridine  (39.3  Ci/ 
mmol).  Equivalent numbers  of infected cells were la- 
beled with [aH]uridine  for 5 min  (4 h 25 min postinfec- 
tion), 20 min (4 h 10 min postinfection) or 120 min (2 h 
30 rain  postinfection). All cells were harvested at 4.5 h 
postinfection.  Labeling  was  stopped  by  pouring  cells 
over frozen, crushed Earle's solution, and a crude cyto- 
plasmic extract was prepared. Non-membrane and mem- 
brane fractions, preparedas described in Materials and 
Methods, were adjusted to 1% in SDS and layered over 
a  ll.6-ml linear  15-30%  (wt/wt)  sucrose  gradient  in 
NETS  buffer.  Centrifugation  was  carried  out  in  the 
Beckman SW41  rotor at 33,000  rpm for 17 h at 23~ 
Fractions were collected from the bottom  of each gra- 
dient and were assayed for trichloroacetic acid-precipita- 
ble radioactivity as previously reported (16). 
min.  After  a  120-min  pulse,  17S  mRNA  com- 
prises  >75%  of labeled  12-18S  VSV mRNA  in 
the  membrane-bound  fraction,  whereas  it  repre- 
sents only a small shoulder in the 17S region in the 
non-membrane  fraction  (Fig.  1 C  and  F).  These 
results  demonstrate  that  all  the  VSV  12-18S 
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thesized in the nonmembrane fraction and that G 
mRNA  rapidly  associates  with  the  membrane- 
bound fraction. 
Experiments  were  performed  to  follow  the 
movement of labeled 17S VSV mRNA from the 
nonmembrane  to the membrane-bound  fraction of 
infected cells after short pulses with  [aH]uridine 
(Fig. 2). In infected cells labeled for 5 rain, most 
of the radioactivity associated with the non-mem- 
brane-bound  fraction is found in 40S subunits and 
monosomes, with higher activity in the 40S region 
(Fig. 2 A). After a  15-rain pulse, labeled RNA in 
40S subunits and monomers of the nonmembrane 
fraction is  increased and some  radioactivity has 
entered the polysome region (Fig. 2 B). Labeling 
of polysomes, however,  is  partially obscured by 
120S nucleocapsids, and some larger polysomes in 
the  nonmembrane fraction  may  be  lost  during 
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FIGURE 2  Labeling of VSV mRNA in polysomes, ri- 
bosomes, and ribosomal subunits in the membrane and 
non-membrane-bound fractions of infected HeLa cells. 1 
x  10  9 HeLa cells were infected with VSV and at 4.5 h 
postinfection equal numbers of cells were labeled with 3 
mCi of  [aH]uridine (37.6 Ci/mmol) for 5 or  15  min. 
Labeling was stopped by the addition of frozen, crushed 
Earle's solution. Membrane and nonmembrane fractions 
were prepared, and polyribosomes were separated and 
analyzed for [SH]uridine-labeled  RNA by centrifugation 
through  a  7-52%  (wt/wt) linear  sucrose gradient  as 
described in Materials and Methods. Absorbance at 254 
nm and the TCA-precipitable radioactivity were deter- 
mined in each fraction as noted in Fig. 1. 
preparation  of  subcellular  components.  In  the 
membrane-bound  fraction of cells pulsed for 5 rain 
(Fig. 2 C), little radioactivity is found in 40S sub- 
units  or  monosomes,  but  some  radioactivity is 
already  present  in  polysomes.  Essentially,  the 
same results were obtained after a 2.5-rain pulse, 
although  the  level  of  radioactive  labeling, was 
lower.  After  a  15-rain pulse,  40S  subunits and 
monomers still show only a low level of labeling; 
however, membrane-bound polysomes are highly 
labeled (Fig. 2 D). Various regions of the gradient 
shown in Fig.  2A (i.e.  polysomes, monosomes, 
40S subunits and supernatant mRNPs) were sepa- 
rated and analyzed for 12-18S VSV mRNA spe- 
cies  by  SDS-sucrose  gradient centrifugation. As 
shown in Fig. 3, labeled 17S mRNA can be identi- 
fied in material isolated from the 40S subunit and 
monomer regions but not in material isolated from 
the mRNP or polysome region. Since the experi- 
ments in  Figs.  2  and  3  were  performed  under 
conditions of continuous labeling, the results indi- 
cate  that  17S  G  mRNA associates initially with 
nonmembrane ribosomes and is then transferred 
to  membrane-bound polysomes without first  cy- 
cling through membrane-bound  subunits or mono- 
somes. 
To be certain that labeled 12-18S RNA in this 
system represents VSV mRNA, a number of ex- 
periments were  performed.  Polysomes were  iso- 
lated from VSV-infected cells, treated with 5 ~,g/ 
ml actinomycin D,  and labeled with  [3Hluridine 
for 1 h. RNA was isolated from these polysomes 
by phenol extraction, and the 12-18S fraction was 
separated by sucrose gradient centrifugation. 85 % 
of labeled RNA in the 12-18S region adsorbed to 
oligo (dT)-eellulose at 0.5 M NaC1-10 mM Tris 
HCI,  pH  7.4  and was  eluted  with  10  mM  Tris 
HC1, pH 7.4 (16). This fraction was hybridized to 
42S RNA isolated from intact virus and, as shown 
in Fig. 4, there was complete protection from T~ 
and pancreatic RNAse degradation as the level of 
42S  virion RNA input was increased. These re- 
suits show that all of the labeled RNA in the 12- 
18S  region represents sequences complementary 
to  42S  virion  RNA,  and  that  the  bulk  of  this 
material is  polyadenylated, i.e.  represents  VSV 
mRNA. 
Effect of Inhibitors of Protein Synthesis 
on Subcellular Localization of G mRNA 
In order to determine whether protein synthesis 
is  necessary for attachment of G  mRNA to the 
membrane-bound fraction,  the  effect  of  certain 
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FIGURE 3  Ribosomal  localization  of  [aH]uridine-la- 
beled  VSV  G  mRNA  in  the  non-membrane  fraction 
after a 5-min  pulse. 3.3  x  l0  s FieLa cells were infected 
with VSV, and at 4 h 45 min postinfection the cells were 
labeled  for  5  min  with  3  mCi  [aH]uridine  (37.6  Ci/ 
mmol). Cells were poured over frozen, crushed Earle's 
solution,  and  a  nonmembrane  fraction  was  prepared. 
The  nonmembrane  fraction  was  layered over a  35-ml 
linear 7-52% (wt/wt) sucrose gradient in isotonic buffer 
containing  100  p,g/ml  heparin,  and  centrifuged in  the 
Beckman SW 27 rotor at  16,000 rpm for 16 h at 4~ 
Fractions were collected and aliquots assayed for trichlo- 
roacetic acid-preeipitable  radioactivity.  The  polysome, 
monosome and 40S regions of the gradient were pooled 
separately, and polysomes and monosomes were precipi- 
tated by addition of 2 vol of absolute ethanol. To sepa- 
rate 40S-mRNA initiation  complexes from supernatant 
mRNPs, the 40S region from a gradient comparable to 
that shown in Fig. 2 A or B (fractions 19-22) was pooled 
and pelleted, resuspended in isotonic buffer containing 
100  /~g/ml  heparin,  and  centrifuged  through  a  35-ml 
linear  15-30%  (wt/wt)  sucrose  gradient  in  isotonic 
buffer containing 100/~g/ml heparin. Under the condi- 
tions of the second gradient, 40S subunits sediment more 
rapidly than supernatant mRNPs, and these components 
can  be separated clearly (16).  Aliquots from each gra- 
dient fraction were assayed  for trichloroacetic acid-pre- 
cipitable  radioactivity,  and  appropriate  fractions  were 
pooled and precipitated by addition of 2 vol of absolute 
ethanol.  Aliquots of each  pooled  sample  were centri- 
fuged in the Sorvall RC-5 at 10,000 rpm for 30 min at 
4~  resuspended in NETS buffer, layered over an 11.6- 
ml linear 15-30%  (wt/wt) sucrose gradient and centri- 
fuged in the Beckman SW41 rotor at 33,000 rpm for 17 
h  at  23~  Fractions  were  collected  and  assayed  for 
protein synthesis inhibitors was studied. At a con- 
centration  of  1  ￿  10 -6  M,  pactamycin  inhibits 
protein  synthesis in VSV-infected cells by  -95% 
(Fig. 5 A). As reported previously by Perlman and 
Huang  (35),  pactamycin  at  this  concentration 
stimulates viral mRNA synthesis (Fig. 5 B). At 4 h 
postinfection,  VSV-infected  cells  were  preincu- 
bated at 37~  for 10 min with 1  x  10 -6 M  pacta- 
mycin,  and  cells  were  labeled  with  [aH]uridine. 
Portions of drug-treated and control infected cells 
were  removed  after  various  time  periods,  and 
membrane-bound  and  nonmembrane  fractions 
were  prepared  and  analyzed  for  labeled  RNA 
(Fig.  6).  In  control  cells,  the  amount  of labeled 
viral RNA increases with time in  both  the  mem- 
brane-bound  and  nonmembrane  fractions.  How- 
ever, in drug-treated  cells, the rate of increase of 
viral  RNA  is  reduced  in  the  membrane-bound 
fraction  and  is  increased  in  the  nonmembrane 
fraction  (Fig. 6A and B). 
To determine  whether the relative decrease  in 
membrane-bound  viral  RNA  in  pactamycin- 
treated cells resulted from a  block in the associa- 
tion of viral mRNA  (specifically G  mRNA) with 
membranes,  [aH]uridine-labeled  viral RNA from 
drug-treated  and  control  ceils  was  analyzed  by 
sucrose gradient centrifugation  (Fig. 7).  Addition 
of pactamycin  reduced  the  level of all three  12- 
18S  VSV mRNA components  in  the membrane- 
bound  fraction,  the  most  prominent  effect being 
that  on  the  17S  component  (Fig.  7A).  At  the 
same  time,  the  proportion  of  17S  mRNA  in  the 
nonmembrane  fraction  increased,  so  that  it  now 
represented  a  defined peak  (Fig.  7 B). The levels 
of [aH]uridine-labeled  17S G  mRNA in the mem- 
brane-bound  fraction  of  equivalent  numbers  of 
cells, in the presence or absence of various protein 
synthesis inhibitors, are listed in Table I. Pactamy- 
cin  reduces  G  mRNA  in  the  membrane-bound 
fraction to 14% of control and muconomycin A  to 
7-8%  of control.  Cycloheximide,  at  100  /zg/ml, 
has a  lesser influence on the amount of labeled G 
mRNA  entering  the  membrane-bound  fraction, 
reducing this value to 57% of control (Table I). At 
this  concentration,  cycloheximide  inhibited  pro- 
tein synthesis in VSV-infected HeLa cells by 97%. 
trichloroacetic  acid-precipitable  radioactivity.  [14C]uri- 
dine-labeled HeLa 18S RNA was used as a marker in a 
parallel gradient. A: 12-18S VSV mRNA in polysome 
region. B:  12-18S VSV mRNA in  monosome region. 
C:  12-18S  VSV  mRNA  in  40S  subunit  region.  D: 
12-18S VSV mRNA in supernatant mRNP region. 
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FIGURE 4  Hybridization  of  [3H]uridine-labeled  12- 
18S  RNA from VSV-infected HeLa cells to VSV 42S 
virion RNA. HeLa cells were infected with VSV for 2.5 
h and labeled with [3H]uridine (30-40 Ci/mmol, 60/zCi/ 
ml)  for  4  h  as  noted  in  Materials  and  Methods. 
[SH]uridine-labeled  12-18S, poly A + RNA was prepared 
from total cytoplasm by phenol extraction, ethanol pre- 
cipitation,  sucrose  gradient  centrifugation,  and  oligo 
(dT)-cellulose chromatography  as described  previously 
(16).  Unlabeled  VSV  42S  RNA  was  prepared  from 
intact virus by SDS-phenol extraction, ethanol precipita- 
tion  and  sucrose gradient  centrifugation  to isolate the 
42S component. Hybridization assays were performed in 
a  5-~tl volume in sealed capillary  tubes containing 200 
mM NaPO4 buffer, pH 6.8-0.5% SDS, 437 cpm 12-18S 
VSV mRNA, and increasing amounts of VSV 42S RNA. 
The  tubes  were heated  at  100~  for  5  rain  and  then 
incubated at  65~  for 15  h. The tubes were placed on 
ice, broken,  and  the samples diluted into  1 ml of 300 
mM NaC1-30 mM Na citrate. 10 ~g of pancreatic RNase 
plus 4 U of T~ RNase in 1 ml of 300 mM NaC1-30 mM 
Na citrate were added and incubation was performed at 
37~  for 30 min. The samples were then placed on ice 
for 10 min, adjusted to 10% TCA, and left on ice for 10 
min.  The  samples  were filtered through  nitrocellulose 
filters,  washed  3  times  with  4  ml  of  5%  TCA,  and 
counted by liquid scintillation  spectroscopy. Blanks of 38 
cpm, representing machine background plus cpm resist- 
ant  to  nuclease  digestion  with  labeled  RNA  samples 
incubated in the absence of 42S virion RNA, were sub- 
tracted from each point. 56 ng of VSV 42S  RNA pro- 
tected  [SH]uridine-labeled  poly  A +  RNA  from  unin- 
fected HeLa cells to only 18 cpm above the blank. 
Experiments were then performed to show that 
G  mRNA was accumulating in the nonmembrane 
fraction  of  pactamycin-treated  cells.  The 
[aH]uridine-labeled 17S component from the non- 
membrane fraction of VSV-infected and pactamy- 
cin-treated  cells  was  isolated  and  applied  to  an 
oligo (dT)-cellulose column.  Approximately 85% 
of this  material was adsorbed  to oligo (dT)-ceUu- 
lose,  indicating  that  it  contained  a  poly  (A)  se- 
quence.  Bound  material  was  eluted  from  oligo 
(dT)-cellulose at low ionic strength  (16)  and ana- 
lyzed further  by  sucrose  gradient  centrifugation. 
Fig. 8 shows that this mRNA sedimented at  17S, 
the normal position for glycoprotein G  mRNA. A 
17S  component  was  also  identified  in  the  non- 
membrane  fraction  of  drug-treated  cells  by  su- 
crose  gradient  centrifugation  in  the  presence  of 
85%  formamide. 
Unlabeled, poly A § RNA from the membrane- 
bound  and  non-membrane-bound  RNA  fraction 
of  control  and  pactamycin-treated  VSV-infected 
cells was isolated and translated  in a  wheat  germ 
mRNA-dependent cell-free system. Both et al. (7) 
have demonstrated  previously in this system  that 
17S VSV mRNA codes for a  63,000-dalton  poly- 
peptide which is glycoprotein G  protein by tryptic 
peptide  analysis  (presumably  minus the carbohy- 
drate  region,  since in vivo synthesized  G  protein 
has a mol wt of 67,000  daltons). As shown by the 
autoradiogram  of the  slab  gel electrophoresis  of 
our cell-free reaction product  (Fig.  9, upper  por- 
tion), a polypeptide of 63,000 daltons is produced 
when  RNA from  VSV-infected cells is  added  to 
the wheat germ system. The relative proportion of 
the  63,000-dalton  polypeptide  (G~K)  is  highest 
and  represents  a  major  coml~onent  with  control 
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FIGURE 5  Effect  of  pactamycin  on  protein  synthesis 
and RNA synthesis  in VSV-infected HeLa cells.  1.5  x 
108  HeLa  cells  were  infected  with  VSV,  and  at  5  h 
postinfection the cells were divided into 4 equal portions. 
Two control fractions  were labeled with either 150  /zCi 
of [SH]-amino acids or 150/zCi of [SH]uridine. The other 
two fractions were labeled with 150/zCi of either tall]- 
amino acids or [ZH]uridine in the presence of 1 x  10 -6 M 
pactamycin.  Incubation was carried out at 37~  for 60 
min.  Duplicate  100-p.l aliquots were removed at  4,  8, 
15,  30, 45  and 60 rain  and transferred to 1 ml of cold 
Earle's solution. Labeled ceils were collected by centrifu- 
gation and resuspended in 1 ml of distilled  H~O. 1 ml of 
10% TCA was added, and the precipitated material was 
collected on a Whatman GF/C glass fiber filter. Radioac- 
tivity  was  determined as described previously (16). A: 
Protein synthesis,  B: RNA synthesis. 
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control  non-membrane-bound  RNA  (slot  D). 
After  addition  of  pactamycin  to  VSV-infected 
,? 
0 
x  7 
o. 
6 
$5 
~4  _J  w 
<  5 
z 
A.  MEMBRANE-BOUND  I 
~Control 
+ Pociomyc~in  ,< 
B,  NON-MEMBRANE  ,,~ 70 
/ 
+ Pacfomycin/￿9 
o ,,"  60  /  r 
'50 
,//  40 
,,'  Coni,ol  30 
/'o  20 
/  ￿9 
IO 
,o  ~o  ~o  ~o  ~o  ~o  ,~  2'0  3'0  4'o  5'0  6'0  0 
TIME  (minutes) 
FIGURE 6  Effect of pactamycin  on  RNA synthesis  in 
non-membrane  and  membrane  fractions  of  VSV-in- 
fected HeLa cells. 8 x  10  a HeLa cells were infected with 
VSV. 1 ￿  10  s cells were removed at 4 h, 4 h 20 rain, 4 h 
40 min, 4 h 50 min, or 4 h 55 min postinfection. At each 
time interval, half the cells were treated with 1 ￿  10 -~ M 
pactamycin  for  10  rain  at  37~  while the  other half 
served as control. Cells were labeled with 400  /zCi  of 
[3H]uridine  (37  Ci/mmol) per  108 cells.  In each case, 
labeling  was  stopped  at  5  h  10  min  postinfection  by 
addition of frozen, crushed Earle's solution. Cells were 
lysed  in  RSB containing  100  p,g/ml heparin, and  non- 
membrane  and  membrane  fractions were  prepared  as 
described. Aliquots from each fraction were assayed  for 
TCA-precipitable radioactivity. A : RNA synthesis in the 
membrane fraction. B: RNA synthesis  in the non-mem- 
brane fraction. 
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cells,  the  proportion  of  G~  synthesized  in  the 
wheat germ system is decreased under direction of 
membrane-bound  RNA (slot C) and  is increased 
under  direction  of  non-membrane-bound  RNA 
(slot  E).  Fig.  9  (lower portion)  shows the  densi- 
tometry scans of the cell-free product in the wheat 
germ system  under  the direction  of VSV-mRNA 
from  control  and  pactamycin-treated  cells.  In 
these tracings,  the profile of the ceil-free product 
is  normalized  to  a  constant  peak  height  for  N 
protein, the major VSV-directed cell-free product. 
With  RNA  from  control  VSV-infected cells,  the 
relative amount of G  synthesized under the direc- 
tion of membrane-bound RNA (determined as the 
area under the 63-k dalton region of the tracing in 
scan  f)  is  approximately  9-fold greater  than  that 
obtained  with  non-membrane-bound  RNA  (scan 
d). This is consistent with the distribution profiles 
for labeled "17S" VSV-mRNA in the membrane- 
bound  versus  the  non  membrane-bound  RNA 
fraction  after  a  2-h  pulse.  The  amount  of  G6a~ 
synthesized  under  the  direction  of  membrane- 
bound  RNA is reduced approximately  50%  after 
treatment of cells with pactamycin (scan f vs. scan 
c), whereas synthesis of G63K under  the direction 
of non-membrane-bound  RNA is increased 400% 
after treatment of cells with pactamycin (scan d vs. 
scan  e).  However,  the  relative  amount  of  G~K 
synthesized  by the sum  of membrane-bound  plus 
non-membrane-bound  RNA from  control  versus 
pactamycin-treated  cells  remains  relatively  con- 
stant  (scans  f  plus  d  vs.  scans  c  plus  e).  This  is 
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FrGURE 7  Influence of pactamycin on distribution of VSV mRNA in membrane and non-membrane- 
bound fractions of infected HeLa cells.  Membrane and nonmembrane fractions from VSV-infected cells, 
labeled  with  [aH]uridine  for  60  min  in  the  presence  or  absence  of  1  x  10  -6  M  pactamycin,  were 
resuspended in buffer containing 1% SDS. Samples were layered over a 15-30% (wt/wt) sucrose gradient 
in NETS buffer and centrifuged in the Beckman SW 41 rotor at 33,000 rpm for 17 h at 23~  Fractions 
were assayed for TCA-precipitable radioactivity. A: Membrane-bound fraction. B: Non-membrane-bound 
fraction. 
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[aH]Uridine-Labeled G mRNA in Membrane- 
Bound Fraction abet Treatment of VSV-Infected 
HeLa Cells with Antibiotic  Inhibitors  of Protein 
Synthesis 
Membrane sample  [aH]Uridine-labeled  17S G 
mRNA 
cpm  % of control 
Control  84,200  - 
+ 10 -~ M pactamycin  11,500  13.6 
+10 -~ M muconomycin A  6,040  7.2 
+100/zg/ml cycioheximide  47,600  57 
At 4  h postinfection, equal numbers of VSV-infected 
HeLa cells were preincubated for 10 min in the pres- 
ence of an antibiotic and subsequently labeled for 60 
min with [3H]uridine.  A control sample was labeled for 
60  min  with  [aH]uridine.  Membrane-bound  fractions 
were prepared, resuspended in NETS buffer, and lay- 
ered  on  15-30%  sucrose  gradients  in  NETS buffer. 
The samples were centrifuged in  the Beckman SW41 
rotor at 33,000  rpm for 17 h at 23~  Fractions were 
assayed  for  TCA-insoluble  radioactivity,  and  the 
amount  of  17S  G  mRNA in  each sample  was  deter- 
mined by estimating the area under the 17S region in 
each gradient. 
consistent  with  earlier  findings  demonstrating  a 
shift  in  labeled  G  mRNA  from  the  membrane- 
bound to the non-membrane-bound  fraction after 
addition  of  pactamycin  to  VSV-infected  HeLa 
cells. 
In  order to  show  that  the  decrease  of  12-18S 
mRNA  in  membrane-bound  polysomes  of  cells 
incubated  with  pactamycin  was  not  the  result  of 
non-specific  release  of  mRNA,  VSV-infected 
HeLa  cells  were  labeled  for  60  min  with 
[aH]uridine  and  the  membrane-bound  polysome 
fraction  was  prepared.  This  fraction  was  resus- 
pended  in  buffer,  incubated  at  37~  for  30  min 
with  various  agents,  and  membranes  were  re- 
collected through a sucrose cushion by a modifica- 
tion of the method of CardeUi et al. (8). Exposure 
of the  membrane-bound  fraction  to  pactamycin, 
cycloheximide, or 0.5 M KC1 resulted in release of 
little  [3H]uridine-labeled  VSV  RNA  (Table  II). 
However,  agents  which  are  known  to  release 
m RNA from polysomes, namely, puromycin -0.5 
M  KCI  and  EDTA,  reduced  [3H]uridine-labeled 
RNA in the membrane-bound fraction by 85%. 
Fate of Prelabeled mRNA  in 
Membrane-Bound  Fraction 
The  results  presented  in  Tables  I  and  II  sug- 
gested  that  pactamycin  and  muconomycin  A 
blocked  entry  of G  mRNA  into  the  membrane- 
bound  fraction,  but  that  cycloheximide was  con- 
siderably  less  effective in  this  function.  We  per- 
formed  experiments  to  follow  the  fate  of prela- 
beled G  mRNA already present in the membrane- 
bound  fraction.  VSV-infected  HeLa  cells  were 
labeled with  [aH]uridine  for 30  min; pactamycin, 
muconomycin A  or cycloheximide was added and 
incubation  continued  for  an  additional  30  min. 
Membrane  fractions  were  prepared,  counted  for 
radioactivity,  and  12-18S  VSV mRNA  was  ana- 
lyzed by sucrose gradient centrifugation. Fig. 10 A 
shows that  total labeled VSV RNA in the mem- 
brane-bound  fraction  is  reduced  after  treatment 
of cells with pactamycin  or muconomycin  A  but 
that  it continues to  increase  after treatment  with 
cycloheximide. In the non-membrane-bound  frac- 
tion (Fig. 10 B), the amount of labeled VSV RNA 
increases,  as  expected.  Table  III  demonstrates 
that  70%  and  90%  of prelabeled  G  mRNA  are 
removed  from  the  membrane-bound  fraction 
after addition of pactamycin and muconomycin A, 
respectively.  Since  G  mRNA  continues  to  enter 
the  membrane-bound  fraction  after  addition  of 
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FIouPJ~  8  Sucrose gradient analysis  of G  mRNA syn- 
thesized in  the presence of pactamycin.  [aH]uridine-la- 
beled 17S mRNA was isolated from the nonmembrane 
fraction  of pactamycin-treated  cells  and  applied  to an 
oligo (dT)-cellulose column in 0.5 M NaCl, 0.01 M Tris, 
pH 7.4, 0.5% SDS buffer. Polyadenylated mRNA was 
eluted from the column with 0.01  M Tris, pH 7.4 and 
precipitated with absolute ethanol.  Labeled RNA was 
pelleted, resuspended  in NETS buffer and  centrifuged 
on a  15-30% sucrose gradient in the Beckman SW 41 
rotor as described in the legend to Fig. 7. Fractions were 
collected and radioactivity was determined as described. 
$0  THE  JOURNAL  OF  CELL  BIOLOGY" VOLUME  74,  1977 FIGURE  9  Autoradiogram and densitometry scans of SDS slab gel electrophoresis of  [3sS]methionine- 
labeled cell-free reaction products synthesized under the direction of membrane-bound and non-mem- 
brane-bound RNA fractions isolated from VSV-infected HeLa cells. 2  ￿  109 HeLa cells, infected with 
VSV for 2.5 h, were divided into two equal aliquots, and 1  ￿  10  -8 M pactamycin was added to one aliquot. 
Incubation of cells was continued for 4  h, and RNA was isolated by SDS-phenol extraction and ethanol 
precipitation of total membrane-bound and non-membrane-bound fractions. Poly A + RNA was prepared 
from these RNA fractions as described in Fig. 8 and translated in a messenger-dependent wheat germ cell- 
free system prepared according to the method of Marcu and Dudock (27). Incubations in a total volume of 
25 bd were performed at 23~  for 2.5 h and contained 20 mM HEPES, pH 7.4, 2.5 mM Mg(Ac)e, 60 mM 
KAc plus 40 mM KCI, 2 mM dithiothreitol, 1 mM ATP, 20/~M GTP, 8 mM creatine phosphate, 16/zg/ml 
creatine phosphokinase, 40/~M phenylmethyi sulfonyl fluoride (a protease inhibitor), 8  /~1 wheat germ 
extract, 27 ~M  19 unlabeled L-amino acids minus methionine, 6  /~Ci L-[~S]methionine (sp act 315 Ci/ 
mmol), and various RNA fractions including poly A + RNA from uninfected cells and poly A + RNA from 
rabbit reticulocytes as controls. Incorporation of [asS]methionine into protein was measured as polypeptide 
insoluble in 5% TCA after heating to 90~  for 20 rain. SDS-slab gel electrophoresis was performed with 
approximately 200,000 cpm of each cell-free reaction product as previously described, using intact virus for 
authentic VSV protein markers (16). Upper portion: Autoradiogram of SDS-slab gel electrophoresis. A : 
No RNA added, 72,566 cpm of cell-free product (the maximum we could apply to the gel) was used in this 
case. B: Poly A + rabbit reticulocyte RNA (under the conditions used, a- and fl-globin polypeptide chains 
migrated with dye front). C: Poly A + RNA from membrane-bound fraction of pactamycin-treated cells, D : 
Poly  A + RNA  from  control non-membrane-bound fraction.  E:  Poly  A + RNA  from  non-membrane- 
bound fraction of pactamycin-treated cells. F: Poly A + RNA from control membrane-bound fraction. G: 
Poly A + RNA from uninfected HeLa cells. Lower portion: Densitometry scans of slots C, D, E and F from 
the autoradiogram of the SDS-slab gel electrophoresis shown above. In these tracings, the sensitivity of the 
scanner was adjusted so that the peak height of VSV N protein (the major VSV-directed cell-free product) 
was 60% of full scale. Since the absolute amount of mRNA added to the system in each experiment is 
unknown, this normalization was required to compare the amount of glycoprotein (3 synthesized under the 
direction of the four separate RNA fractions; (f) membrane-bound RNA, control VSV-infected cells; (c) 
membrane-bound  RNA,  pactamycin-treated,  VSV-infected  cells;  (d)  non-membrane-bound  RNA 
control VSV-infected cells; (e) non-membrane-bound RNA, pactamycin-treated, VSV-infected cells. The 
position of authentic VSV protein markers NS, N and M and the 63-k dalton band from the autoradiogram 
are indicated. TABLE II 
In-vitro Release  of  [3H]Uridine-Labeled VSV-RNA 
from the Membrane-Bound Fraction of Infected 
HeLa Cells 
Fractions 
cpm  % 
release 
A  Control  5,338  0 
B  +0.5 M KCI  4,959  9 
C  +0.5 M KCI-1 mM puromycin  875  84 
D  +30 mM EDTA  796  85 
E  +10 -e M pactamycin  4,580  14 
F  +100 /zg/ml cycloheximide  4,550  15 
At 3.5 h postinfection, 1.5  x  108 VSV-infected HeLa 
cells were labeled for 60 min with 3 mCi [3H]uridine.  A 
membrane-bound fraction was prepared,  resuspended 
in buffer (20 mM Tris HCI, pH 7.4, 25 mM KCI, 5 mM 
MgCIz,  1 mM dithiothreitol,  100  /zg/ml heparin),  and 
divided into six equal portions. Each of these fractions 
was incubated at 37~  for 30 min under varying condi- 
tions: (A) buffer; (B) buffer containing 0.5 M KCI; (C) 
buffer containing 0.5 M KCI and 1 mM puromycin; (D) 
buffer containing 30 mM EDTA; (E) buffer containing 
10 -6 M pactamycin; and (F) buffer containing 100 ~g/ 
ml cycloheximide. After incubation, the various mem- 
brane-bound  fractions were layered over a  5-ml 30% 
(wt/wt) sucrose cushion in buffer (samples A and D-F) 
or in 0.5 M KCI buffer (samples B and C) and centri- 
fuged in the Beckman SW 41  rotor at 30,000 rpm for 
30 min at 4~  The pellets were resuspended in 250 p.1 
of buffer containing heparin.  2  ml of 10%  TCA was 
added,  and  the  precipitated  radioactivity was  deter- 
mined as in previous tables and figures. 
cycloheximide, similar analysis  could not  be per- 
formed with this inhibitor. 
Ribosomal Localization  of G  mRNA 
in  Drug  Treated Cells 
We  were  interested  in  determining  the  ribo- 
somal  localization  of  G  mRNA  in  drug-treated 
cells. VSV-infected HeLa cells were preincubated 
with either muconomycin A  or cycloheximide and 
subsequently labeled for 60 min with [3H]uridine. 
Cells  were  lysed  and  polysomes  resolved  on  su- 
crose  gradients.  Fig.  11 A  shows  that,  in  control 
cells, VSV mRNA is present in 40S subunits,  80S 
monomers and  polysomes of various sizes. In the 
presence  of  1  ￿  10 -6  M  muconomycin  A  (Fig. 
11 B), labeled mRNA is present predominantly in 
monomers,  with a  very small  amount  of label in 
40S  subunits.  With  cycloheximide,  however,  re- 
sidual  dimers,  trimers  and  tetramers  are  present 
and  are  labeled  with  VSV-mRNA  (Fig.  11C). 
The  ribosomal  fraction  of  VSV-infected  cells 
treated  with cycloheximide also contains twice as 
much  [~4C]leucine-labeled  nascent  polypeptide 
chain  as  that  obtained  from  cells  treated  with 
muconomycin  A  (data not shown). 
The 40S subunit and 80 monomer regions from 
the  nonmembrane  fraction  of  muconomycin  A- 
treated  cells  were  isolated  after  a  60-min  pulse 
with  [aH]uridine  (Fig.  12).  Both the 40S subunit 
and  80S  monomer  fractions  contained  all  three 
species of 12-18S mRNA. 
DISCUSSION 
The  results  presented  in  this  paper  suggest  that 
formation  of  membrane-bound  polysomes  in 
VSV-infected HeLa cells occurs after protein syn- 
thesis is initiated and that the nascent polypeptide 
chain is required to maintain integrity of mRNA- 
membrane  interaction.  Our  results  are  based  on 
analysis of a specific viral mRNA, glycoprotein G 
mRNA.  This mRNA  is found  almost  exlcusively 
in  the  membrane-bound  fraction,  and  its transla- 
tion product,  G  protein,  is transferred  across the 
plasma  membrane  to  become  part  of  the  outer 
envelope of the  mature  virus  (18).  We have  fol- 
lowed the fate of newly synthesized G  mRNA by 
labeling VSV-infected cells with [3H]uridine in the 
presence  or absence  of inhibitors  of protein  syn- 
thesis.  Pulse-labeling  experiments  indicate  that 
17S  G  mRNA  is synthesized  in  the  cytosol frac- 
tion.  This  is  consistent  with  the  finding  that  a 
soluble  VSV-transcription  complex  sediments  at 
140S in VSV-infected Chinese hamster ovary cells 
(33).  Newly synthesized G  mRNA rapidly associ- 
ates with 40S ribosomal subunits and subsequently 
with 80S monomers in the nonmembrane fraction. 
We  have  not  been  able  to  detect  G  mRNA  in 
polysomes of the  non-membrane-bound  fraction. 
Labeled VSV G  mRNA is present in the mem- 
brane-bound fraction of infected HeLa cells within 
5  min  after  a  pulse  with  [3H]uridine.  However, 
even after this very short labeling period, radioac- 
tive VSV mRNA is found  in  small polysomes of 
the  membrane-bound  fraction,  whereas  little  ra- 
dioactivity  is  present  in  40S  subunits  or  mono- 
mers.  Within  20 min after pulse labeling of these 
cells, G  mRNA comprises more than  75%  of the 
12-18S mRNA in the membrane-bound  fraction, 
and this mRNA is present predominantly in poly- 
somes. The amount of G  mRNA in the polysome 
region  of  the  membrane-bound  fraction  is  also 
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F]out~  10  Redistribution of  [6H]-VSV  RNA  in  subcellular polysome  fractions of  HeLa  cells after 
addition  of  protein  synthesis  inhibitors.  HeLa  cells  were  infected  with  VSV,  and,  at  3  h  40  min 
postinfection,  equal  portions of cells were  labeled with  [aH]uridine.  After  30  rain,  one  portion  was 
analyzed for [3H]uridine-labeled RNA in the membrane-bound and non-membrane-bound fractions. No 
drug (control), 1 x  10  -6 M pactamycin, 1 x  10  -6 M muconomycin A, or 100/~g/ml cycloheximide was 
added to the remaining portions of cells and incubation was continued for an additional 30 min. The 
membrane-bound and non-membrane-bound fractions from these cells were isolated, and  [aH]uridine- 
labeled VSV RNA was determined by trichioroacetic acid precipitation. A: Membrane-bound fraction. B: 
Non-membrane-bound fraction. 
TABLE llI 
Release of Prelabeled [6H]-Uridine G mRNA from 
the Membrane-Bound  Fraction after Treatment of 
HeLa Cells with Antibiotic  lnhibitors  of Protein 
Synthesis 
Membrane sample  17S G  mRNA 
cpm  % release 
Control (30')  37,600  - 
Control (30') +  10  -6 M pactamy-  11,212  70 
cin (30') 
Control (30')  +  10  -8 M  mucono-  3,800  90 
mycin A  (30') 
At 3 h 40 min postinfection, VSV-infected HeLa cells 
were divided into equal portions, and each was labeled 
for  30  min  with  [6H]uridine.  The  membrane-bound 
fraction was prepared from one sample, while the other 
samples were incubated for an additional 30 min in the 
presence of  1  ￿  10  -6  M  pactamycin  or  1  x  10  -6  M 
muconomycin A. Membranes were prepared from each 
of these samples, and 12-18S mRNA was analyzed by 
sucrose  gradient  centrifugation.  The  amount  of  G 
mRNA  in  the  membrane-bound  fraction  of  drug- 
treated cells was compared to the amount of G mRNA 
present in  30-min labeled,  untreated cells.  Based  on 
the data in Table I, a correction was made for entry of 
[6H]uridine-labeled  G  mRNA  into  the  membrane- 
bound  fraction  during  the  second  30-min  period  of 
incubation with pactamycin or muconomycin A. 
greater  than  that  found  in  the  40S  subunit  or 
monomer  pool  after  a  5-min  or  15-rain  pulse. 
Since we have been unable to detect a progression 
of labeled  17S  G  mRNA  from  subunits to  poly- 
somes within the membrane-bound fraction, it ap- 
pears that G  mRNA is present in polysomes, or at 
least  in  oligosomes,  at the time of its association 
with membranes. 
We  reasoned  that,  if association  of G  mRNA 
with the membrane-bound fraction requires prior 
mRNA-ribosome  interaction  and  synthesis  of  a 
nascent polypeptide chain, then inhibition of pro- 
tein synthesis at the  appropriate  step would  pre- 
vent formation of an mRNA-ribosome-membrane 
complex.  To  examine  this  question,  we  used  a 
number of inhibitors of protein synthesis to deter- 
mine the requirements for entry of VSV G  mRNA 
into  the  membrane-bound  fraction.  Pactamycin 
and muconomycin A  (also known as verrucarin A) 
are inhibitors of initiation of protein synthesis, the 
former allowing formation of an mRNA-40S sub- 
unit complex  (9,  20, 21),  and the latter blocking 
initiation after formation of an  mRNA-80S  mon- 
omer  complex  (2,  26).  The  very  low  level  of 
protein synthesis observed in the presence of these 
drugs  at  1  ￿  10 -6  M  (less  than  5%  of control) 
probably represents individual cells or polysomes 
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Fmuw  11  Influence of muconomycin A and cycloheximide on polysome size and VSV mRNA distribu- 
tion. 1 x  10  a HeLa cells were infected with VSV, and at 4 h postinfection the cells were divided into 3 
equal portions. 1 x  10 -a M muconomycin A or 100 ~tg/ml cycloheximide was added to separate portions, 
and  one portion was  left as control.  After 10  rain  in the presence or absence of muconomycin A  or 
cycloheximide, 0.8  mCi  [SH]uridine  (37  Ci/mmol)  was  added  to  control  and  drug-treated  cells  and 
incubation was continued for an additional 60 min. Total polysome fractions were prepared, layered on 7- 
52% (wt/wt) sucrose gradients, and centrifuged in the SW27 rotor as described. Gradient fractions were 
monitored for optical density  at  254  nm,  and  TCA-precipitable radioactivity was  determined in  each 
fraction. A: Control cells. B: Muconomycin A-treated ceils.  C: Cydoheximide-treatetl cells. 
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FIGURE 12  Sucrose  gradient  analysis  of VSV  12-18S 
mRNA species  present in 80S monomers and 40S sub- 
units of non-membrane-bound fraction of muconomycin 
A-treated VSV-infected HeLa cells.  The  80S  and  40S 
regions from the non-membrane fraction of muconomy- 
ein  A-treated  VSV-infeeted  cells  were  isolated  and 
precipitated  with  ethanol.  The  samples  were  resus- 
pended in NETS buffer, layered on a  15-30%  sucrose 
gradient, and centrifuged in the Beckman SW41 rotor as 
described in  the legend to Fig.  7.  Fractions were col- 
lected and radioactivity was determined. 
which escaped inhibition. Utilizing these antibiot- 
ics,  we  find  that  formation  of  polysomes  is  in- 
hibited and that entry of G  mRNA into the mem- 
brane fraction is suppressed up to 80-90%. Under 
these circumstances, labeled 17S mRNA accumu- 
lates in the non-membrane  fraction. 
Rosbash  (39)  has  previously studied  the  influ- 
ence  of cycloheximide on  association  of mRNA 
with membranes in uninfected HeLa cells. Cyclo- 
heximide  inhibits  elongation  of  polypeptide 
chains, rather than  initiation of protein  synthesis, 
and allows formation of small polysomes (9,  13). 
In  Rosbash's  studies,  there  was  only  a  30-35% 
reduction  of  labeled  HeLa  cell  mRNA  in  the 
membrane-bound  polysome  fraction  after  addi- 
tion of cycloheximide, although protein  synthesis 
was inhibited by 98%.  In addition, labeled HeLa 
cell  mRNA  was  found  predominantly  in  mono- 
somes and  disomes,  although  some material  was 
present in trisomes (39).  Using the VSV-infected 
HeLa cell system, we have confirmed the observa- 
tions of Rosbash for a specific mRNA, G  mRNA. 
Thus, we find that cycloheximide reduces the level 
of  [aH]uridine-labeled  G  mRNA  in  the  mem- 
brane-bound fraction to 57% of control (Table I). 
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and muconomycin A, which inhibit the initiation 
of protein synthesis but  do  not  prevent mRNA- 
40S subunit association (pactamycin) or mRNA- 
80S monomer formation (muconomycin A), have 
a significantly greater effect on G  mRNA associa- 
tion  with  membranes  than  cycloheximide. This 
is consistent with an interpretation that synthesis 
of the nascent chain is a  prerequisite for associa- 
tion  of G  mRNA  with  the  membrane  fraction. 
Furthermore,  from  in  vitro  experiments  with 
membranes prelabeled with VSV mRNA and in- 
cubated in the presence of 1 mM puromycin -0.5 
M KC1, we find no evidence for direct association 
of labeled mRNA  or  mRNA-40S  subunits  with 
membranes. 
Since  pactamycin  and  muconomycin  A  inhib- 
ited  interaction  of  G  mRNA  with  membranes 
but  did  not  cause  dissociation  of  preformed 
mRNA-membrane  complexes,  we  were  able  to 
perform "pulse-chase" experiments to follow the 
fate of G  mRNA which had already entered the 
membrane-bound fraction. If G  mRNA were di- 
rectly associated with membranes, then  addition 
of  inhibitors  of  protein  synthesis  to  preformed 
complexes should have little effect. However, we 
found  that  70-90%  of pfelabeled G  mRNA  is 
released from the membrane-bound fraction after 
addition of pactamycin or muconomycin A. This 
suggested  that  G  mRNA-membrane  interaction 
depends  upon  a  linkage  which  is  sensitive  to 
protein  synthesis  inhibition.  Release  of  labeled 
mRNA  from  the  membrane-bound  fraction  in 
vitro by puromycin -0.5 M KC1 is consistent with 
this interpretation. 
The results reported here support a  model for 
segregation  of  membrane-bound  polysomes  re- 
cently proposed by Blobel and co-workers (3, 5, 
6).  According to this model, termed the  "signal 
hypothesis",  formation  of  polyribosomes  and 
translation of mRNA for all proteins begins in the 
cytosol compartment of the cell. Those  mRNAs 
whose translation products are to be transferred 
across a membrane first synthesize a hydrophobic 
N-terminal peptide, which serves as the signal for 
recognition by the membrane. Polysomes contain- 
ing this hydrophobic peptide or "signal sequence" 
attach  to  the  membrane,  polypeptide  synthesis 
continues, and vectorial transfer of protein across 
the  membrane  occurs  (3,  5,  6).  Therefore,  it is 
the N-terminal sequence of the growing polypep- 
tide chain,  rather  than  the  primary sequence  of 
mRNA, which serves as the signal for recognition 
by the membrane. 
We would like to emphasize that  our present 
results have been  obtained with one  specific la- 
beled RNA, glycoprotein G  mRNA.  Studies by 
other investigators reporting a  direct association 
of poly (A) containing mRNA  with  membranes 
are based primarily on in  vitro  treatment of iso- 
lated  membranes  with  various agents  known  to 
remove ribosomes from membranes (8,  24,  30). 
Under  such  conditions, a  varying portion  of la- 
beled mRNA  may remain with  membranes, de- 
pending  upon  the  cell type,  labeling conditions 
and treatment utilized (8, 24, 30). Certain studies 
have  suggested  that  mRNA-protein  complexes 
(mRNPs)  may be involved in mRNA-membrane 
interaction (8, 24, 28-30), and mRNP complexes 
involving the 3'-poly (A) region of mRNA have 
been described (4, 23, 42). Recently, Adesnik et 
al.  (2)  reported  a  direct  association of  mRNA 
with the membrane fraction in human fibroblasts 
after in vivo inhibition of initiation of protein syn- 
thesis (2).  However, these and other studies (8, 
24,  30) have examined total or a  mixed popula- 
tion of membrane mRNAs rather than an mRNA 
for a specific protein. Since membranes may con- 
tain  mRNAs  for  secreted  proteins,  membrane 
constituent  proteins  and  possibly  certain  intra- 
cellular  proteins  (10-12,  17,  25,  38),  specific 
mRNAs  in  different  systems  may  have  varying 
affinities or mechanisms for interaction with ribo- 
somes and membranes, and further studies will be 
needed to examine this question. 
Received for publication 24 January 1977, and in revised 
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